A phase III multicenter trial comparing two different sequences of second/third line therapy (cetuximab/irinotecan followed by FOLFOX versus FOLFOX...

Date 28 September 2015
Event European Cancer Congress 2015
Session Gastrointestinal Malignancies - Colorectal Cancer II
Topics Colon Cancer
Rectal Cancer
Presenter Cascinu, S.